Non-Alcoholic Fatty Liver Disease Trial, Recruiting (NCT07518784)

Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT07518784 Sponsor: University of California, San Diego Condition: Non-Alcoholic Fatty Liver Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07518784 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Non Alcoholic Fatty Liver Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with, or are suspected by a doctor to have, a liver condition called MASLD (a type of fatty liver disease)
People with a body mass index (BMI) between 27 and 45 at the time of being referred to the study
People who are able to lie still on a special device table for around 60 minutes
People who are able to hold their breath repeatedly for about 20 seconds during scanning procedures
People who are willing and able to take part in all parts of the study

Who may not be able to join:

People who work for UCSD or Livivos as study staff
People who have a medical reason why they cannot have an MRI scan (confirm with trial site)
People who know they are pregnant, think they may be pregnant, or are trying to become pregnant
People who have a known long-term liver disease other than MASLD

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 21 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Claude B Sirlin, MD, University of California, San Diego

Phone: 858-246-2198

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07518784

Sponsor: University of California, San Diego

Phase: Not Applicable

Status: Recruiting

Condition: Non-Alcoholic Fatty Liver Disease

Trial contact: 858-246-2198

More information: https://clinicaltrials.gov/study/NCT07518784

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with, or are suspected by a doctor to have, a liver condition called MASLD (a type of fatty liver disease)
People with a body mass index (BMI) between 27 and 45 at the time of being referred to the study
People who are able to lie still on a special device table for around 60 minutes
People who are able to hold their breath repeatedly for about 20 seconds during scanning procedures
People who are willing and able to take part in all parts of the study

Who may not be able to join:

People who work for UCSD or Livivos as study staff
People who have a medical reason why they cannot have an MRI scan (confirm with trial site)
People who know they are pregnant, think they may be pregnant, or are trying to become pregnant
People who have a known long-term liver disease other than MASLD

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 21 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Diego

Registry

ClinicalTrials.gov

Start date

8 April 2026

Est. completion

30 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Agreement of LiverScope® measurements compared to conventional MR; Repeatability and reproducibility of LiverScope® measurements

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov